Chemoinformaics analysis of 7-EPI-GANODERIC-ACID
| Molecular Weight | 357.274 | nRot | 3 |
| Heavy Atom Molecular Weight | 346.186 | nRig | 22 |
| Exact Molecular Weight | 357.048 | nRing | 4 |
| Solubility: LogS | -3.871 | nHRing | 1 |
| Solubility: LogP | 3.885 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 3 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 16 |
| nHA | 7 | APOL | 43.2407 |
| nHD | 2 | BPOL | 18.2773 |
| QED | 0.416 |
| Synth | 2.748 |
| Natural Product Likeliness | 0.632 |
| NR-PPAR-gamma | 0.427 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.994 |
| MDCK | 0.0000267 |
| BBB | 0.036 |
| PPB | 0.946875 |
| VDSS | 0.637 |
| FU | 0.0760185 |
| CYP1A2-inh | 0.708 |
| CYP1A2-sub | 0.351 |
| CYP2c19-inh | 0.102 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.72 |
| CYP2c9-sub | 0.473 |
| CYP2d6-inh | 0.78 |
| CYP2d6-sub | 0.137 |
| CYP3a4-inh | 0.144 |
| CYP3a4-sub | 0.025 |
| CL | 2.376 |
| T12 | 0.665 |
| hERG | 0.034 |
| Ames | 0.559 |
| ROA | 0.068 |
| SkinSen | 0.486 |
| Carcinogencity | 0.889 |
| EI | 0.492 |
| Respiratory | 0.842 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.696329 |